Market Closed -
Toronto S.E.
03:31:48 2024-05-01 pm EDT
|
5-day change
|
1st Jan Change
|
0.035
CAD
|
0.00%
|
|
-12.50%
|
0.00%
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
31.55
|
69.68
|
8.552
|
4.851
|
4.244
|
-
|
-
|
Enterprise Value (EV)
1 |
31.55
|
69.68
|
8.552
|
4.851
|
4.244
|
4.244
|
4.244
|
P/E ratio
|
-4.25
x
|
-4.63
x
|
-0.32
x
|
-0.5
x
|
-0.65
x
|
-0.65
x
|
-0.65
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
158
x
|
-
|
6
x
|
13.3
x
|
-
|
-
|
-
|
EV / Revenue
|
158
x
|
-
|
6
x
|
13.3
x
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-5,331,969
x
|
-398,279
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-7,404,388
x
|
-6,080,848
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
5.47
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
46,401
|
62,776
|
71,266
|
121,266
|
121,266
|
-
|
-
|
Reference price
2 |
0.6800
|
1.110
|
0.1200
|
0.0400
|
0.0350
|
0.0350
|
0.0350
|
Announcement Date
|
6/24/20
|
6/24/21
|
6/29/22
|
6/23/23
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
0.1991
|
-
|
1.424
|
0.3641
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-13.07
|
-21.47
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-6.092
|
-15.66
|
-24.62
|
-7.884
|
-8.415
|
-10.32
|
-10.72
|
Operating Margin
|
-
|
-3,059.51%
|
-
|
-1,728.55%
|
-2,165.69%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-5.416
|
-14.33
|
-25.08
|
-9.207
|
-6.922
|
-10.32
|
-10.72
|
Net income
1 |
-4.331
|
-5.416
|
-14.3
|
-25.12
|
-9.2
|
-6.922
|
-10.32
|
-10.72
|
Net margin
|
-
|
-2,720.36%
|
-
|
-1,763.42%
|
-2,527.06%
|
-
|
-
|
-
|
EPS
2 |
-0.1400
|
-0.1600
|
-0.2400
|
-0.3800
|
-0.0800
|
-0.0540
|
-0.0540
|
-0.0540
|
Free Cash Flow
|
-
|
-4.261
|
-11.46
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-2,140.22%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/3/19
|
6/24/20
|
6/24/21
|
6/29/22
|
6/23/23
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
0.00494
|
1.391
|
0.00547
|
0.00484
|
0.00909
|
-
|
0.3408
|
0.00833
|
0.3397
|
0.484
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-11.17
|
-3.299
|
-2.444
|
-2.059
|
-1.186
|
-2.423
|
-2.225
|
-2.223
|
-1.48
|
-1.914
|
-2.172
|
Operating Margin
|
-226,176.11%
|
-237.21%
|
-44,678.24%
|
-42,540.91%
|
-13,046.09%
|
-
|
-653.02%
|
-26,683.55%
|
-435.87%
|
-395.48%
|
-
|
Earnings before Tax (EBT)
1 |
-11.17
|
-3.23
|
-3.334
|
-2.314
|
-1.653
|
-2.585
|
-2.654
|
-1.536
|
-0.9345
|
-0.1462
|
-2.172
|
Net income
1 |
-11.18
|
-3.239
|
-3.333
|
-2.325
|
-1.638
|
-2.619
|
-2.647
|
-1.5
|
-0.9766
|
-0.1523
|
-2.172
|
Net margin
|
-226,248.18%
|
-232.91%
|
-60,940.59%
|
-48,032.23%
|
-18,022.22%
|
-
|
-776.77%
|
-18,007.2%
|
-287.51%
|
-31.48%
|
-
|
EPS
2 |
-0.1800
|
-0.0500
|
-0.0500
|
-
|
-0.0100
|
-0.0200
|
-0.0200
|
-
|
-
|
-
|
-0.0140
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/12/21
|
2/14/22
|
6/29/22
|
8/12/22
|
11/10/22
|
2/14/23
|
6/23/23
|
8/11/23
|
11/14/23
|
2/13/24
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-4.26
|
-11.5
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-133%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
0.2000
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-0.1900
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
0
|
0.01
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
0.54%
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/3/19
|
6/24/20
|
6/24/21
|
6/29/22
|
6/23/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 3.08M | | -1.17% | 104B | | +2.87% | 97.47B | | +2.13% | 22.25B | | -14.77% | 21.68B | | -8.79% | 18.2B | | -39.98% | 17.02B | | -13.21% | 16.36B | | +8.55% | 14.39B | | +35.75% | 12.37B |
Bio Therapeutic Drugs
|